AstraZeneca
The Director, Enterprise AI Process & Innovation will lead the translation of strategy into scalable AI outcomes across AstraZeneca’s critical end‑to‑end processes, partnering with senior leaders to identify high‑impact use cases and ensure robust, production‑ready solutions. This hands‑on leadership role involves shaping AI‑enabled process improvements, guiding multi‑disciplinary teams, and embedding responsible AI governance to drive measurable business value and patient impact.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
5% above the average for this role